GlassScriptPhysician profile
Larry R Taub
NPI 1902805229
$4,464.37
in general payments reported to CMS, 2019-2025
22 companies · $851 in 2025
The $851 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790 · 2020: $287 · 2021: $471 · 2022: $560 · 2023: $909 · 2024: $595 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006 · Long Term Medical Supply Or Device Loan: $327 · Entertainment: $22.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.24 |
| Long Term Medical Supply Or Device Loan | $327.14 |
| Entertainment | $22.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,503.13 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Carl Zeiss Meditec USA, INC. | $444.05 | 2021-2023 | Cirrus 5000 With Angioplex, Iolmaster 700 |
| Tarsus Pharmaceuticals, INC. | $432.81 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $374.50 | 2019-2024 | Tecnis Iol |
| Abbvie INC. | $366.16 | 2022-2025 | Durysta, Lumigan, Vuity |
| Allergan, INC. | $192.24 | 2020-2022 | |
| Rxsight INC | $181.98 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Bausch & Lomb Americas INC. | $159.16 | 2022-2023 | Vyzulta, Prolensa, Miebo |
| Amgen INC. | $148.29 | 2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $146.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $113.00 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $105.67 | 2019-2020 | |
| Halozyme INC | $77.30 | 2021-2024 | Hylenex Recombinant |
| Eyevance Pharmaceuticals LLC | $50.69 | 2019-2020 | |
| Beaver-Visitec International, INC. | $33.32 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.99 | 2021 | |
| Optos, INC. | $22.52 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Mallinckrodt Hospital Products INC. | $21.82 | 2021 | |
| Eyepoint US, INC. | $21.71 | 2019 | |
| Oyster Point Pharma, INC. | $19.73 | 2022 | |
| Alcon Research LLC | $19.37 | 2019 | |
| Glaukos Corporation | $7.58 | 2023 | Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Taub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.